Abstract
Background and objective:
Systemic inflammation is a well-known risk factor for diseases such as atherosclerosis and is augmented by the presence of obesity. In addition, it has been shown that inflammation may be negatively influenced by certain macronutrients, specifically the omega-3 and omega-6 fatty acids. The primary aim of this study is to determine whether obesity modifies the association between plasma phospholipid polyunsaturated fatty acids (PUFAs) and markers of inflammation and endothelial activation in Multi-Ethnic Study of Atherosclerosis (MESA) participants.
Subjects:
A sample of 2848 adults (25% African American, Chinese, Hispanic, and White) randomly selected from the MESA cohort.
Measurements:
Relative plasma PUFA concentrations were determined using gas chromatography-flame ionization detection. Levels of three inflammatory markers (high-sensitivity C-reactive protein, interleukin (IL)-6 and tumor necrosis factor-receptor 1) and two endothelial activation markers (soluble intercellular adhesion molecule-1 (sICAM-1) and E-selectin) were determined with enzyme immunoassays. Linear regression analysis was used to evaluate the relationship between these markers and plasma PUFAs.
Results:
Obesity modified the associations of linoleic acid (Pint=0.01), dihomo-γ-linolenic (Pint=0.07) and eicosapentaenoic acid (EPA) (Pint=0.04) with sICAM-1 concentrations; in addition, obesity modified the association of IL-6 with dihomo-γ-linolenic (Pint=0.01). In obese individuals, sICAM-1 was inversely related to EPA levels (P=0.02), but directly related to linoleic acid levels (P<0.001). Conversely, sICAM-1 was inversely related to linoleic acid levels in normal weight individuals (P=0.04). IL-6 concentrations were significantly and directly related to dihomo-γ-linolenic acid (DGLA) in normal weight (P=0.01) and obese participants (P<0.001), but the scale of increase across tertiles was greater in obese adults. Main effects of fatty acid and inflammatory marker associations are also reported.
Conclusion:
The modifying effect of obesity on the association of plasma PUFAs with IL-6 and sICAM-1 suggests differences in fatty acid metabolism and may also have implications in dietary fatty acid intake for obese individuals, particularly for linoleic and EPAs. Further study is warranted to confirm and explain the strong associations of DGLA with inflammatory and endothelial activation markers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Shah PK . Plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Clin 1999; 17: 271–281.
Hansson GK . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.
Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH . Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005; 26: 1765–1773.
Fain JN . Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443–477.
Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589–600.
Wall R, Ross RP, Fitzgerald GF, Stanton C . Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010; 68: 280–289.
Lindqvist HM, Sandberg AS, Fagerberg B, Hulthe J . Plasma phospholipid EPA and DHA in relation to atherosclerosis in 61-year-old men. Atherosclerosis 2009; 205: 574–578.
GISSI-Prevenzione Investigators. Dietary supplementation with n–3 polyunsaturated fatty acids and vitamin E in 11 324 patients with myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447–455.
Sun Q, Ma J, Campos H, Rexrode KM, Albert CM, Mozaffarian D et al. Blood concentrations of individual long-chain omega-3 fatty acids and risk of nonfatal myocardial infarction. Am J Clin Nutr 2008; 88: 216–223.
Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995; 274: 1363–1367.
Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR . Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2: 117–119.
Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB . Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108: 155–160.
Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439–446.
Kalogeropoulos N, Panagiotakos DB, Pitsavos C, Chrysohoou C, Rousinou G, Toutouza M et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010; 411: 584–591.
Chapkin RS, Kim W, Lupton JR, McMurray DN . Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 187–191.
Tian H, Lu Y, Sherwood AM, Hongqian D, Hong S . Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest Ophthalmol Vis Sci 2009; 50: 3613–3620.
Hu FB, Manson JE, Willett WC . Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001; 20: 5–19.
Moussavi N, Gavino V, Receveur O . Could the quality of dietary fat, and not just its quantity, be related to risk of obesity? Obesity (Silver Spring) 2008; 16: 7–15.
Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119: 902–907.
Laaksonen DE, Nyyssönen K, Niskanen L, Rissanen TH, Salonen JT . Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005; 165: 193–199.
Browning LM, Krebs JD, Moore CS, Mishra GD, O’Connell MA, Jebb SA . The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 2007; 9: 70–80.
Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871–881.
Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY . Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006; 52: 2265–2272.
Park HS, Park JY, Yu R . Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 2005; 69: 29–35.
Matsumoto K, Sera Y, Abe Y, Tominaga T, Horikami K, Hirao K et al. High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus. Metabolism 2002; 51: 932–934.
Fernández-Real JM, Broch M, Vendrell J, Ricart W . Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003; 26: 1362–1368.
Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C . Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005; 82: 1178–1184.
Blond JP, Henchiri C, Bézard J . Delta 6 and delta 5 desaturase activities in liver from obese Zucker rats at different ages. Lipids 1989; 24: 389–395.
Araya J, Rodrigo R, Pettinelli P, Araya AV, Poniachik J, Videla LA . Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity (Silver Spring) 2010; 18: 1460–1463.
Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto Jr AM et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997; 96: 4219–4225.
Levin G, Duffin KL, Obukowicz MG, Hummert SL, Fujiwara H, Needleman P et al. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2. Biochem J 2002; 365: 489–496.
Iversen L, Fogh K, Kragballe K . Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway. Arch Dermatol Res 1992; 284: 222–226.
Leslie CC . Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol 2004; 82: 1–17.
Rao NL, Dunford PJ, Xue X, Jiang X, Lundeen KA, Coles F et al. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton. J Pharmacol Exp Ther 2007; 321: 1154–1160.
Stuhlmeier KM, Kao JJ, Bach FH . Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-kappaBalpha/nuclear factor-kappaB (NF-kappaB) complex, thus suppressing the nuclear translocation of NF-kappaB. J Biol Chem 1997; 272: 24679–24683.
Ji Q, Zhang L, Jia H, Xu J . Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci 2004; 34: 427–436.
Sodin-Semrl S, Taddeo B, Tseng D, Varga J, Fiore S . Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J Immunol 2000; 164: 2660–2666.
Rassias G, Kestin M, Nestel PJ . Linoleic acid lowers LDL cholesterol without a proportionate displacement of saturated fatty acid. Eur J Clin Nutr 1991; 45: 315–320.
Hodson L, Skeaff CM, Chisholm WA . The effect of replacing dietary saturated fat with polyunsaturated or monounsaturated fat on plasma lipids in free-living young adults. Eur J Clin Nutr 2001; 55: 908–915.
Calder P . N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003; 38: 343–352.
Serhan CN, Arita M, Hong S, Gotlinger K . Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004; 39: 1125–1132.
Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A et al. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 2008; 112: 848–855.
Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, Serhan CN . Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007; 178: 3912–3917.
Schwab JM, Chiang N, Arita M, Serhan CN . Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007; 447: 869–874.
Lo CJ, Chiu KC, Fu M, Lo R, Helton S . Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res 1999; 82: 216–221.
Zhao Y, Joshi-Barve S, Barve S, Chen LH . Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 2004; 23: 71–78.
Di Nunzio M, Danesi F, Bordoni A . n-3 PUFA as regulators of cardiac gene transcription: a new link between PPAR activation and fatty acid composition. Lipids 2009; 44: 1073–1079.
Norling LV, Serhan CN . Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination. J Intern Med 2010; 268: 15–24.
Register TC, Burdon KP, Lenchik L, Bowden DW, Hawkins GA, Nicklas BJ et al. Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem 2004; 50: 2185–2187.
Acknowledgements
We thank the other investigators, staff and participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org. This study was supported by the following contracts, N01-HC-95159 through N01-HC-95169 from the National Heart, Lung and Blood Institute.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Steffen, B., Steffen, L., Tracy, R. et al. Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis. Int J Obes 36, 797–804 (2012). https://doi.org/10.1038/ijo.2011.157
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2011.157
Keywords
This article is cited by
-
Impact of Fatty Acids on Obesity-Associated Diseases and Radical Weight Reduction
Obesity Surgery (2022)
-
Age-related compositional changes and correlations of gut microbiome, serum metabolome, and immune factor in rats
GeroScience (2021)
-
Metabolomic biomarkers in midtrimester maternal plasma can accurately predict the development of preeclampsia
Scientific Reports (2020)
-
Evaluation of all Types of Metabolic Bariatric Surgery and its Consequences: a Systematic Review and Meta-Analysis
Obesity Surgery (2019)
-
The associations of serum n-6 polyunsaturated fatty acids with serum C-reactive protein in men: the Kuopio Ischaemic Heart Disease Risk Factor Study
European Journal of Clinical Nutrition (2018)